Former President and Chief Executive Officer, Amylin Pharmaceuticals

Ginger L. Graham is the former President and Chief Executive Officer of Amylin Pharmaceuticals. Prior to this, Graham was Group Chairman, Office of the President for Guidant Corporation, a major cardiovascular medical device manufacturer. In addition, Graham serves on the Boards of Directors for Genomic Health Inc., Proteus Digital Health Pharmaceutical Division, Surefire Medical, Elcelyx Therapeutics, Clovis Oncology Inc. and the Circle of Life Hospice Foundation. She is a member of the Harvard Business School Health Industry Alumni Advisory Board, the University of Arkansas Chancellor’s Campaign Steering Committee and the Advisory Board for the BioFrontiers Institute at the University of Colorado. She also serves on the Advisory Board for the Kellogg Center for Executive Women and co-chairs the Scientific Council of the University of Colorado’s Center for Women’s Health Research.

You must be logged in to view this item.

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.